GLR Partners, LLC

Position in PGEN — Precigen, Inc.

CIK 2134831 COLUMBIA, MD

Position in PGEN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$798,963

-$795,658 QoQ

Shares Held

140,169

-66.0% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

#73

of 208 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GLR Partners, LLC holds $1,837,830 across 3 Biotechnology names. PGEN ranks #2 (43.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BRNS	Barinthus Biotherapeutics plc.	1,243,377	$820,628
2	PGEN	Precigen, Inc. This page	140,169	$798,963
3	REGN	Regeneron Pharmaceuticals, Inc.	350	$218,239

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$798,963	140,169	-66.0%	Shares	Sole	2026-07-27
2026-03-31	$1,594,621	412,047	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.